BioPharma Credit (LON:BPCR – Get Free Report) insider Graeme Proudfoot purchased 70,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 29th. The stock was acquired at an average price of GBX 99 per share, with a total value of £69,300.
BioPharma Credit Trading Down 0.4%
BPCR traded down GBX 0 during midday trading on Wednesday, hitting GBX 0.98. 2,413,558 shares of the company traded hands, compared to its average volume of 1,392,099. The company has a market capitalization of £11.00 million, a price-to-earnings ratio of 0.09 and a beta of 0.23. BioPharma Credit has a 52-week low of GBX 0.88 and a 52-week high of GBX 1. The business has a 50 day simple moving average of GBX 0.97 and a two-hundred day simple moving average of GBX 0.96.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than BioPharma Credit
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
